Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

One child had secondary hyperparathyroidism associated with a profound vitamin D deficiency [PTH: 159.8 pg/ml; 25(OH)D: 20 nmol/L].

Source: Clinical data. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

To limit the impact of scoliosis on the acquisition of lumbar spine measurements, the children were examined in a position that stretched the spine as possible.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Bone health in children with severe cerebral palsy

Study design awaiting verification · Frontiers in Pediatrics · 2023

Original publication title

Bone health in children with severe cerebral palsy

Vincent Barbier; Vincent Goeb; Richard Gouron; Severine Fritot; Romuald Mentaverri; Céline Klein

© 2023 Barbier, Goeb, Gouron, Fritot, Mentaverri and Klein.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What objectives does the paper state?

To describe bone health and associated factors in children with severe cerebral palsy.

Source: Aim

Abstract: What methods does the paper describe?

In a retrospective, single-centre study, we performed a comprehensive bone evaluation (including clinical, densitometric and bone biomarker assessments) of children with severe cerebral palsy.

Source: Method

Abstract: Discussion

Our results highlights the insufficient increase in bone mass with age (probably due to excessive bone remodelling) and confirms the high prevalence of low bone mineral density in children with severe cerebral palsy. Possible preventive measures might include calcium + vitamin D supplementation and the systematic management of underweight and delayed puberty. Bone remodelling markers might be of value for follow-up.

Source: Discussion

Abstract: Results

None of the 19 included children had a normal BMCTBLH Z score, and only one had a BMDTBLH Z score greater than −2. Six children had a BMDLS Z score greater than −2. The bone biomarker data were suggestive of excessive bone remodelling. Levels of bone remodelling markers factors and densitometric variables were not significantly related. Age, weight and pubertal stage were significantly related to bone mass.

Source: Results
Authors’ abstract

Aim

To describe bone health and associated factors in children with severe cerebral palsy.

Method

In a retrospective, single-centre study, we performed a comprehensive bone evaluation (including clinical, densitometric and bone biomarker assessments) of children with severe cerebral palsy.

Results

None of the 19 included children had a normal BMCTBLH Z score, and only one had a BMDTBLH Z score greater than −2. Six children had a BMDLS Z score greater than −2. The bone biomarker data were suggestive of excessive bone remodelling. Levels of bone remodelling markers factors and densitometric variables were not significantly related. Age, weight and pubertal stage were significantly related to bone mass.

Discussion

Our results highlights the insufficient increase in bone mass with age (probably due to excessive bone remodelling) and confirms the high prevalence of low bone mineral density in children with severe cerebral palsy. Possible preventive measures might include calcium + vitamin D supplementation and the systematic management of underweight and delayed puberty. Bone remodelling markers might be of value for follow-up.

Publication and source details

Original title: Bone health in children with severe cerebral palsy

Vincent Barbier; Vincent Goeb; Richard Gouron; Severine Fritot; Romuald Mentaverri; Céline Klein

Frontiers in Pediatrics · 2023

Edited by: Giuseppina Sgandurra, Stella Maris Foundation (IRCCS), Italy

Reviewed by: Federica Saponaro, University of Pisa, Italy Maria Teresa Botti Rodrigues Santos, Universidade Cruzeiro do Sul, Brazil

* Correspondence: Vincent Barbier vincent.barbier426@gmail.com

Abbreviations CP, cerebral palsy; BMD, bone mineral density; LS, lumbar spine; ISCD, international society for clinical densitometry; BMC, bone mineral content; TBLH, total body less head; GMFCS, gross motor functional classification system; DXA, dual-energy x-ray absorptiometry; 25 (OH) D, 25 hydroxy vitamin D; IGF-1, insulin-like growth factor 1; PTH, parathyroid hormone; BALP, bone alkaline phosphatase; OC, osteocalcin; CTX, C telopeptide of type 1 collagen.

© 2023 Barbier, Goeb, Gouron, Fritot, Mentaverri and Klein.2023Barbier, Goeb, Gouron, Fritot, Mentaverri and Kleinhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:46:32.626676+00:00

DOI: 10.3389/fped.2023.1264111 · PMC10716435